SG Americas Securities, LLC

Broker-Dealer

Position in VERA — Vera Therapeutics, Inc.

CIK 1313360 NEW YORK, NY

Position in VERA

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$1,088,111

+$579,162 QoQ

Shares Held

25,358

+100.4% QoQ

Ownership

0.035%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#110

of 217 holders

Holding Since

Mar 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SG Americas Securities, LLC holds $1,085,838,933 across 181 Biotechnology names. VERA ranks #68 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	427,703	$266,689,928
2	VRTX	Vertex Pharmaceuticals Inc / Ma	523,720	$260,147,435
3	URGN	UroGen Pharma Ltd.	2,052,906	$75,546,940
4	CGON	CG Oncology, Inc.	867,465	$61,633,388
5	PTCT	Ptc Therapeutics, Inc.	605,581	$49,397,242
6	ASND	Ascendis Pharma A/S	161,026	$42,948,854
7	RPRX	Royalty Pharma plc	688,590	$38,609,241
8	BNTX	BioNTech SE	347,131	$32,300,539

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,088,111	25,358	+100.4%	Shares	Sole	2026-08-07
2026-03-31	$508,949	12,651	-52.1%	Shares	Sole	2026-04-16
2025-12-31	$1,336,592	26,394	-15.8%	Shares	Sole	2026-01-09
2025-09-30	$910,885	31,345	+229.4%	Shares	Sole	2025-10-23
2025-03-31	$228,598	9,517	-53.0%	Shares	Sole	2025-04-15
2024-12-31	$857,218	20,270	+116.7%	Shares	Sole	2025-01-17
2024-09-30	$413,446	9,354	+117.5%	Shares	Sole	2024-10-03
2024-06-30	$155,610	4,301	-64.0%	Shares	Sole	2024-07-12
2024-03-31	$514,895	11,941	+54.9%	Shares	Sole	2024-05-06
2023-12-31	$118,564	7,709	-46.4%	Shares	Sole	2024-01-12
2023-03-31	$111,619	14,384	—	Shares	Sole	2023-04-28
No filing history on record for this holder in this stock.